evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract
9935,GENE_BACKGROUND,,"CDK4 encodes the cyclin-dependent kinase 4, a serine/threonine kinase that regulates the cell cycle G1 to S phase transition. Upon mitogen stimulation, CDK4 forms a complex with cyclin-dependent kinase 6 (CDK6) and cyclin D, which leads to activation of the kinases (PMID: 12432268). The active CDK4/CDK6 complex then phosphorylates and inactivates retinoblastoma (RB), thereby inducing the gene expression program (which includes mediators of the cell cycle) regulated by the E2F family of transcription factors. CDK4/6 are in turn negatively regulated by p16INK4a (encoded by cyclin-dependent kinase inhibitor 2A gene, CDKN2A) which binds to the catalytic domains of the kinases and interferes with cyclin D and ATP binding (PMID: 9751050, 11124804). As CDK4 is a controller of the cell cycle checkpoint, deregulation of its activity by amplification, activating mutations or inactivating p16INK4a is often observed in cancers. Amplification of CDK4 are often reported in sarcomas, glioblastoma and breast cancers (PMID: 8221695, 8044775, 8586464, 9916925). On the contrary, activating mutations of CDK4 in cancers are very rare, with only a few cases of CDK4 mutations at codon 22 and 24 reported in sporadic/hereditary melanoma and lung carcinoma (PMID: 7652577, 9425228, 11828258).",,2017-04-17,,1019,CDK4,cyclin dependent kinase 4,True,ENST00000257904,NM_000075.3,PSK-J3,CMM3,False,8586464,Gene amplification in human gliomas.,Glia,0001-11-01,15,3,289-96,Collins VP,,,0001-11-01,,7652577,A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.,"Science (New York, N.Y.)",0001-09-01,269,5228,1281-4,WÃ¶lfel T et al,,,0001-09-01,,12432268,Cycling to cancer with cyclin D1.,Cancer biology &amp; therapy,2018-05-01T20:02:00,True,3,226-31,Diehl JA,,,0001-05-01,,9425228,Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.,Human molecular genetics,0001-02-01,7,2,209-16,Soufir N et al,,,0001-02-01,,8221695,Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.,Cancer research,0001-11-15,53,22,5535-41,Khatib ZA et al,,,0001-11-15,,8044775,"Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2.",Cancer research,0001-08-15,54,16,4299-303,Reifenberger G et al,,,2018-08-15T03:03:00,,9751050,Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.,Nature,0001-09-17,395,6699,237-43,Russo AA et al,,,0001-09-17,,11828258,Rarity of CDK4 germline mutations in familial melanoma.,Melanoma research,2018-02-01T20:02:00,12,True,1951-05-01,Goldstein AM et al,,,0001-02-01,,11124804,Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.,Genes &amp; development,2017-12-15T20:00:00,14,24,3115-25,Jeffrey PD et al,,,0001-12-15,,9916925,Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation.,The American journal of pathology,0001-01-01,154,True,113-8,An HX et al,,,0001-01-01,
9934,GENE_SUMMARY,,"CDK4, an intracellular kinase, is altered by amplification or mutation in a diverse range of cancers including liposarcomas.",,2017-04-17,,1019,CDK4,cyclin dependent kinase 4,True,ENST00000257904,NM_000075.3,PSK-J3,CMM3,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
